EveryCat Health Foundation
https://everycat.org
2022 Feline Health Grants
15 Grants Funded for a Total of $353,711

Sixty-seven grant proposals focused on cat health were received for the 2021 EveryCat Health Foundation Grant cycle. After a diligent, rigorous review by scientific advisors, board members, and a statistician, 15 proposals were selected for funding by the Foundation's Grant Review Committee. Awards for this grant cycle totaled just over $353,000.00 USD.

Grant proposals are received from researchers throughout the world and are diverse in feline health topics. Past highlights include the discovery of taurine as the major cause of dilated cardiomyopathy, the use of high protein/low carbohydrate diets as the mainstay treatment of diabetes mellitus, discovery of feline blood types, development of in-clinic Feline Leukemia tests, treatment of asthma with metered dose inhalant therapy, effective antiviral therapy for FIP, and many, many other accomplishments.

EveryCat Health Foundation's collaborative work is made possible through the generosity of sponsors and donors. "We fund innovative health studies that advance veterinary knowledge and expertise. As the world's only nonprofit foundation committed solely to supporting cat health research – EveryCat Health Foundation helps your cat, my cat, community cats – all cats, everywhere," Jackie Ott Jaakola, Executive Director, EveryCat Health Foundation.

EveryCat Health Foundation awarded grants for the following research studies:

Bria Fund Study

Determining the invitro intrinsic clearance (feline microsomes) and in vivo pharmacokinetic profile of remdesivir in cats with naturally occurring feline infectious peritonitis (FIP). $23,626
Principal Investigator(s): Dr. Sally Coggins, Associate Professor Merran Govendir, and Dr. Benjamin Kimble; Sydney School of Veterinary Science, The University of Sydney, Australia. (New Investigator Award) W21-006

Feline peritoneal- and ascites-associated macrophages in health and in cats with feline infectious peritonitis: leveraging an anticoronaviral clinical trial. $25,000
Principal Investigator(s): Sarah Cook, DVM, MS, DACVP; University of California, Davis. (New Investigator Award) W21-007

Development of a Rapid CRISPR CasRx Diagnostic Tool for Feline Infectious Peritonitis. $15,521
Principal Investigator(s): Krystle Reagan; University of California, Davis. (New Investigator Award) (Sponsored by IDEXX) W21-010

Use of a liposome-toll-like receptor complex (LTC) immune stimulant in the treatment of effusiveFIP – A clinical trial. $29,674
Principal Investigator(s): Petra Cerna; Michael Lappin; Steven Dow; Colorado State University. W21-017

Determining the clinical efficacy and safety of remdesivir for the treatment of naturally occurring feline infectious peritonitis. $29,100
Principal Investigator(s): Professor Jacqueline Norris; Dr. Sally Coggins; Associate Professor Mary Thompson; Sydney School of Veterinary Science, The University of Sydney, Australia. (New Investigator Award) W21-018

Creation of a Feline Living Bioarchive and Feline Induced Pluripotent Stem Cells for Use in Investigations into Feline Tooth Resorption & Other Feline Diseases. $29,998
Principal Investigator(s): Dr. Gurå Therese Bergkvist; Royal (Dick) School of Veterinary Studies & The Roslin Institute, The University of Edinburgh, Scotland. W21-035

Creation of a Feline Living Bioarchive and Feline Induced Pluripotent Stem Cells for Use in Investigations into Feline Tooth Resorption & Other Feline Diseases $29,988
Principal Investigator(s): Dr. Gurå Therese Bergkvist; Royal (Dick) School of Veterinary Studies & The Roslin Institute, The University of Edinburgh, Scotland. W21-035

Ricky Rund Study

Comparison of Echocardiography and Biomarkers in Cats Eating High- or Low-Pulse Diets”. $29,661
Principal Investigator(s): Dr. Lisa Freeman; Cummings School of Veterinary Medicine at Tufts University. (Sponsored in Memory of “Bu”) W21-028

Kitty Kollar Fund Study

Intestinal S100/Calgranulin expression in cats with Chronic Enteropathy- Paving the way for novel non-invasive biomarkers and pathway-specific treatment options. $3,975
Principal Investigator(s): Drs. Romy M. Heilmann and Denny Böttcher, Leipzig University; Dr. Corinne Gurtner, Bern University. (Kitty Kollar Fund) (Sponsored by IDEXX) W21-030

Glucagon-like peptide 2 in cats with inflammatory bowel disease. $29,815
Principal Investigator(s): Maria Jugan; Kansas State University. W21-032

Feline Kidney Fund, in honor of Dr. Vicki Thayer

Hormonal regulation of appetite in cats with and without chronic kidney disease. $20,906
Principal Investigator(s): Drs. Jessica Quimby and Sarah Lorbach; The Ohio State University. W21-042

Andorra Fund Study

PPARαas metabolic target to restore intestinal permeability in an intestinal organoid model offline diabetic enteropathy. $29,530
Principal Investigator(s): Amir Kol; University of California. (Andora Fund and Cures4Cats Diabetes Fund)  W21-046

D-Dimer isolation and analysis of immunoreactivity in dogs, cats and horses. $3,000
Principal Investigator(s): Juliet Brown; University of Melbourne, Australia. W21-048

General Studies

Whole Exome Sequencing to Identify Candidate Gene and Immunotherapy Treatment Options in Feline Oral Squamous Cell Carcinoma. $25,000
Principal Investigator(s): Shirley Chu; Wesley Warren; University of Missouri. (New Investigator Award-Genomics) (Sponsored by Wisdom Health) W21-002

Effects of early life experiences on later problematic behaviors in rescued, fostered, shelter kittens.” $28,975
Principal Investigator(s): Karen Overall; Associate Professor Kathryn Proudfoot; Associate Professor and Director, Sir James Dunn Animal Welfare Centre; Dr. Chelsea K. Martin; William J. Montelpare, Ph.D.; Margaret and Wallace McCain: Atlantic Veterinary College, University of Prince Edward Island, Canada. (Sponsored by PetSmart Charities) W21-015

Development of a questionnaire for the detection of cognitive decline in elderly cats. $30,000
Principal Investigator(s): Niwako Ogata; Hsin-Yi Weng, Purdue University. W21-064